D. Hanahan and R. A. Weinberg, The hallmarks of cancer, Cell, vol.100, pp.57-70, 2000.

A. Chapple, S. Ziebland, and A. Mcpherson, Stigma, shame, and blame experienced by patients with lung cancer: qualitative study, BMJ, vol.328, p.1470, 2004.

N. K. Loconte, N. M. Else-quest, J. Eickhoff, J. Hyde, and J. H. Schiller, Assessment of guilt and shame in patients with non-small-cell lung cancer compared with patients with breast and prostate cancer, Clin Lung Cancer, vol.9, pp.171-178, 2008.

G. Myrdal, M. Lambe, G. Hillerdal, K. Lamberg, T. Agustsson et al., Effect of delays on prognosis in patients with non-small cell lung cancer, Thorax, vol.59, pp.45-49, 2004.

N. Leveque, L. Brouchet, and B. Lepage, An analysis of delays in the management of thoracic cancers: a prospective study, Rev Mal Respir, vol.31, pp.208-213, 2014.

J. H. Schiller, D. Harrington, and C. P. Belani, Eastern Cooperative Oncology Group. Comparison of four chemotherapy regimens for advanced nonsmall-cell lung cancer, N Engl J Med, vol.346, pp.92-98, 2002.

G. V. Scagliotti, S. Novello, and S. Rapetti, Current state-of-the-art therapy for advanced squamous cell lung cancer, Am Soc Clin Oncol Educ Book, vol.33, pp.354-358, 2013.

L. G. Paz-ares, F. De-marinis, and M. Dediu, PARAMOUNT: final overall survival results of the phase III study of maintenance pemetrexed versus placebo immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer, J Clin Oncol, vol.31, pp.2895-2902, 2013.

F. Barlesi, A. Scherpereel, and A. Rittmeyer, Randomized phase III trial of maintenance bevacizumab with or without pemetrexed after first-line induction with bevacizumab, cisplatin, and pemetrexed in advanced nonsquamous non-small-cell lung cancer: AVAPERL (MO22089), J Clin Oncol, vol.31, pp.3004-3011, 2013.

R. Rosell, E. Carcereny, and R. Gervais, Spanish Lung Cancer Group in collaboration with Groupe Français de Pneumo-Cancérologie and Associazione Italiana Oncologia Toracica. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial, Lancet Oncol, vol.13, pp.239-246, 2012.

A. T. Shaw, D. W. Kim, and K. Nakagawa, Crizotinib versus chemotherapy in advanced ALK-positive lung cancer, N Engl J Med, vol.368, pp.2385-2394, 2013.

R. Ramos, P. Girard, C. Masuet, P. Validire, and D. Gossot, Mediastinal lymph node dissection in early-stage non-small cell lung cancer: totally thoracoscopic vs thoracotomy, Eur J Cardiothorac Surg, vol.41, pp.1342-1350, 2012.

D. R. Aberle, A. M. Adams, and C. D. Berg, Reduced lung-cancer mortality with low-dose computed tomographic screening, N Engl J Med, vol.365, pp.395-409, 2011.

N. Kalampalikis and S. Moscovici, Une approche pragmatique de l'analyse Alceste, Les Cah Int Psychol Soc, vol.66, pp.15-24, 2005.
URL : https://hal.archives-ouvertes.fr/halshs-00116255

D. Buchanan, R. Milroy, L. Baker, A. M. Thompson, and P. A. Levack, Perceptions of anxiety in lung cancer patients and their support network, Support Care Cancer, vol.18, pp.29-36, 2010.

D. Sagan, J. Sak, M. Wiechetek, J. Pawlikowski, E. Olszewska et al., Differences in psychological perception of lung cancer between patients, medical staff and medical students, Eur J Cardiothorac Surg, vol.41, pp.607-611, 2012.

Q. Li, C. Dresler, and J. E. Heck, Knowledge and beliefs about smoking and cancer among women in five European countries, Cancer Epidemiol Biomarkers Prev, vol.19, pp.2811-2820, 2010.

C. Dresler, The changing epidemic of lung cancer and occupational and environmental risk factors, Thorac Surg Clin, vol.23, pp.113-122, 2013.

J. F. Gamble, M. J. Nicolich, and P. Boffetta, Lung cancer and diesel exhaust: an updated critical review of the occupational epidemiology literature, Crit Rev Toxicol, vol.42, pp.549-598, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01263002

M. Oberg, M. S. Jaakkola, A. Woodward, A. Peruga, and A. Prüss-ustün, Worldwide burden of disease from exposure to second-hand smoke: a retrospective analysis of data from 192 countries, Lancet, vol.377, pp.139-146, 2011.

D. J. Fischer, D. Villines, Y. O. Kim, J. B. Epstein, and D. J. Wilkie, Anxiety, depression, and pain: differences by primary cancer, Support Care Cancer, vol.18, pp.801-810, 2010.

D. Hanahan and R. A. Weinberg, Hallmarks of cancer: the next generation, Cell, vol.144, pp.646-674, 2011.

E. Vallières, F. A. Shepherd, and J. Crowley, International Association for the Study of Lung Cancer International Staging Committee and Participating Institutions. The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer, J Thorac Oncol, vol.4, pp.1049-1059, 2009.

J. A. Howington, M. G. Blum, A. C. Chang, A. A. Balekian, and S. C. Murthy, Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer, Chest, vol.143, issue.5, pp.278-313, 2013.

L. F. Rutten, B. W. Hesse, R. P. Moser, K. D. Mccaul, and A. J. Rothman, Public perceptions of cancer prevention, screening, and survival: comparison with state-of-science evidence for colon, skin, and lung cancer, J Cancer Educ, vol.24, pp.40-48, 2009.

J. C. Weeks, P. J. Catalano, and A. Cronin, Patients' expectations about effects of chemotherapy for advanced cancer, N Engl J Med, vol.367, pp.1616-1625, 2012.

R. J. Gralla, M. J. Edelman, and F. C. Detterbeck, Assessing quality of life following neoadjuvant therapy for early stage non-small cell lung cancer (NSCLC): results from a prospective analysis using the Lung Cancer Symptom Scale (LCSS), Support Care Cancer, vol.17, pp.307-313, 2009.